First Trust Advisors LP Clovis Oncology, Inc. Transaction History

First Trust Advisors LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 04, 2019	SELL	$3.93 - $15.35 $190,990 - $745,979	-48,598 Closed	0 $0
Q2 2019 Jul 30, 2019	BUY	$12.81 - $25.67 $622,540 - $1.25 Million	48,598 New	48,598 $723,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.